Three biotech IPOs begin trading

|By:, SA News Editor

The hot offering of the day following yesterday's near-triple in Dicerna Pharmaceuticals (DRNA) is Ultragenyx Pharmaceutical (RARE), which raised $121M after pricing its IPO at $21 each vs. an expected range of $14-$17. The company also upsized the offering amount by 1M shares to 5.8M.

Cara Therapeutics (CARA) raised $55M after selling 5M shares at the low end of the expected $11-$13 range.

Trevena (TRVN) - which two months ago postponed its offering due to market conditions - raised $64.75M after pricing its IPO at $7 per share.